Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland

被引:33
作者
Atta, Mohamed G. [1 ]
Fine, Derek M. [1 ]
Kirk, Gregory D. [2 ,4 ]
Mehta, Shruti H. [4 ]
Moore, Richard D. [3 ,4 ]
Lucas, Gregory M. [2 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
D O I
10.1086/523728
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. African Americans with human immunodeficiency virus type 1 (HIV-1) infection and kidney disease are at increased risk of end-stage renal disease requiring renal replacement therapy (RRT), particularly in urban areas with high rates of poverty and injection drug use. It is unknown how the widespread use of highly active antiretroviral therapy (HAART) has affected survival during RRT in this vulnerable population. Methods. African American patients infected with HIV-1 who required RRT were identified from 2 cohorts that included 4509 Africans Americans infected with HIV-1 who were recruited during the period 1988-2004 in Baltimore, Maryland. Survival after initiation of RRT was compared for those who initiated treatment in the pre-HAART and the HAART eras using Kaplan-Meier curves. Cox proportional hazards regression analysis was used to adjust for potential confounders. Results. RRT was initiated in 162 patients (3.6%) during 10.6 years of follow-up (119 during the HAART era). Compared with patients who started RRT in the pre-HAART era, those in the HAART era were older (P < .001) and more likely to have CD4 cell counts of <= 200 cells/mm(3) (P = .01). A total of 126 patients (78%) died during follow-up; among those who initiated RRT during the HAART era, 87 deaths occurred (73%). Median survival time in the pre-HAART era was 22.4 months (95% confidence interval [CI], 9.3-30.7); during the HAART era, it was 19.9 months (95% CI, 14.7-26.5;). In the multiple Cox regression model, factors independently Pp. 94 associated with increased mortality included age (hazard ratio [HR], 1.30; 95% CI, 1.06-1.60; P = .01), lower serum albumin level (HR, 0.72; 95% CI, 0.57-0.91;), lower CD4 cell count (HR, 0.90; 95% CI, 0.82-0.99; P <.03), and the lack of HAART (HR, 0.52; 95% CI, 0.33-0.82; P = .005). Conclusions. Older age, lower serum albumin level, lower CD4 cell count, and the lack of HAART are independent predictors of poor survival among African Americans infected with HIV-1 undergoing RRT in a resource-limited urban area. RRT survival was similar in the pre-HAART and HAART eras, likely reflecting inadequate HIV treatment in this population.
引用
收藏
页码:1625 / 1632
页数:8
相关论文
共 30 条
[1]  
Abbott KC, 2001, J NEPHROL, V14, P377
[2]  
Acchiardo SR, 1983, KIDNEY INT S, V16, pS199
[3]   Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States [J].
Ahuja, TS ;
Grady, J ;
Khan, S .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1889-1893
[4]   Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients [J].
Ahuja, TS ;
Borucki, M ;
Grady, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :574-580
[5]  
[Anonymous], 2006, USRDS 2006 ANN DAT R
[6]   Antiretroviral therapy in the treatment of HIV-associated nephropathy [J].
Atta, Mohamed G. ;
Gallant, Joel E. ;
Rahman, M. Hafizur ;
Nagajothi, Nagapradeep ;
Racusen, Lorraine C. ;
Scheel, Paul J. ;
Fine, Derek M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (10) :2809-2813
[7]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503
[8]   Is there an epidemic of HIV infection in the US ESRD program? [J].
Eggers, PW ;
Kimmel, PL .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (09) :2477-2485
[9]   HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients [J].
Estrella, Michelle ;
Fine, Derek M. ;
Gallant, Joel E. ;
Rahman, M. Hafizur ;
Nagajothi, Nagapradeep ;
Racusen, Lorraine C. ;
Scheel, Paul J. ;
Atta, Mohamed G. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) :377-380
[10]  
Ifudu O, 1997, AM J KIDNEY DIS, V29, P549, DOI 10.1016/S0272-6386(97)90336-X